HDAC-IN-82
HDAC-IN-82 (Compound 18b) is a histone deacetylase (HDAC) inhibitor with selective antiplasmodial and anticancer activity. HDAC-IN-82 shows potent antiproliferative activity and caspase 3/7 activation in cancer cells. HDAC-IN-82 causes hyperacetylation of histone H3 and α-tubulin[1].
Product Specifications
UNSPSC
12352005
Target
Caspase; HDAC; Parasite
Type
Reference compound
Related Pathways
Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac-in-82.html
Smiles
O=C(C1=CN=C(N2CCC(CN(C3(C(NCC4=CC=CC=C4)=O)CNCC3)C=O)CC2)N=C1)NO
Molecular Formula
C24H31N7O4
Molecular Weight
481.55
References & Citations
[1]Stopper D, et al. Multicomponent syntheses enable the discovery of novel quisinostat-derived chemotypes as histone deacetylase inhibitors. Eur J Med Chem. 2025 Jan 5;281:117045.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Caspase 3; Caspase 7
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP311137M 100 µg
HMG2L1 (HMGXB4) (NM_005487) Human Recombinant Protein
Sign In for Pricing
View Details 
TP327863M 100 µg
Apoptosis inhibitor 5 (API5) (NM_001142931) Human Recombinant Protein
Sign In for Pricing
View Details